Previous 10 | Next 10 |
AMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEK PR Newswire EMERYVILLE, Calif. , March 17, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable...
AMYRIS CLOSES ACQUISITION OF MENOLABS PR Newswire EMERYVILLE, Calif. , March 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its La...
Image source: The Motley Fool. Amyris (NASDAQ: AMRS) Q4 2021 Earnings Call Mar 01, 2022 , 9:00 a.m. ET Operator Continue reading For further details see: Amyris (AMRS) Q4 2021 Earnings Call Transcript
Amyris, Inc. (AMRS) Q4 2021 Earnings Conference Call March 01, 2022 09:00 AM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President & Chief Executive Officer Conference Call Participants Colin Rusch - Oppenheimer Dan Brennan - Cowen Laurence Alexander - Je...
Amyris (NASDAQ:AMRS) is expecting a very bullish 2022, so much so that its newly issued financial guidance calls for a 150% increase in consumer revenue year over year. The company made the announcement as part of its Q4 2021 results Tuesday morning, in which it beat on the top line but misse...
The following slide deck was published by Amyris, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Amyris, Inc. 2021 Q4 - Results - Earnings Call Presentation
Amyris press release (NASDAQ:AMRS): Q4 GAAP EPS of -$0.43 misses by $0.23. Revenue of $64.78M (-18.7% Y/Y) beats by $10.15M. For further details see: Amyris GAAP EPS of -$0.43 misses by $0.23, revenue of $64.78M beats by $10.15M
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS - 2021 full year total revenue grew 97% year-over-year to $342 million - Q4 and full year 2021 consumer revenue +86% and +78% respectively versus prior year - Accelerating consumer growth and new pa...
Amyris (NASDAQ:AMRS) is scheduled to announce Q4 earnings results on Tuesday, Mar. 1, before market open. The consensus EPS estimate is -$0.16 (-433.3% Y/Y) and the consensus revenue estimate is $54.63M (-31.5% Y/Y). Over the last 2 years, AMRS has beaten EPS estimates 25% of the time and has...
ADT,AGEN,AKBA,ALBO,AMRN,AMRS,AXSM,AZO,OTCPK:BAYZF,BIDU,BLDR,BMO,BNS,BSY,CCCS,CHS,CMRX,CRON,DPZ,EHTH,EPZM,EVRI,FOUR,OTCQX:GTBIF,HGV,HOV,HRL,HTA,HZNP,IGT,IQ,ITCI,KSS,KTB,LILM,MANU,MCRB,MLCO,NFE,OTCQB:NLST,NUWE,OKE,PIRS,PLTK,PRGO,QTRX,REGI,RYTM,SE,SJM,TGT,TGTX,TLS,TWNK,UWMC,VFF,VRTV,WEN,WKHS,XXI...
News, Short Squeeze, Breakout and More Instantly...
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This gr...
2023-08-14 06:00:00 ET 3 Tips for New Penny Stocks Traders Penny stocks, often priced below $5 per share, present an enticing opportunity for investors looking to diversify their portfolios and potentially reap significant returns. While these stocks can be volatile, with the right stra...
2023-08-12 06:54:00 ET 3 Tips for Predicting When a Penny Stock Will Breakout in Price Penny stocks, often priced below $5, have garnered significant attention from investors due to their potential for substantial returns. Predicting breakouts in penny stocks can be both an art and ...